Richard J. Creger

1.4k total citations
60 papers, 986 citations indexed

About

Richard J. Creger is a scholar working on Hematology, Oncology and Public Health, Environmental and Occupational Health. According to data from OpenAlex, Richard J. Creger has authored 60 papers receiving a total of 986 indexed citations (citations by other indexed papers that have themselves been cited), including 26 papers in Hematology, 21 papers in Oncology and 11 papers in Public Health, Environmental and Occupational Health. Recurrent topics in Richard J. Creger's work include Hematopoietic Stem Cell Transplantation (18 papers), Neutropenia and Cancer Infections (9 papers) and Acute Lymphoblastic Leukemia research (9 papers). Richard J. Creger is often cited by papers focused on Hematopoietic Stem Cell Transplantation (18 papers), Neutropenia and Cancer Infections (9 papers) and Acute Lymphoblastic Leukemia research (9 papers). Richard J. Creger collaborates with scholars based in United States, Türkiye and Germany. Richard J. Creger's co-authors include Hillard M. Lazarus, Brenda Cooper, R M Fox, Stanton L. Gerson, Tamila L. Kindwall‐Keller, Michael R. Jacobs, William Tse, Lisa M. Arfons, Hillard M. Lazarus and Pingfu Fu and has published in prestigious journals such as Journal of Clinical Oncology, Blood and Clinical Infectious Diseases.

In The Last Decade

Richard J. Creger

58 papers receiving 962 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Richard J. Creger United States	19	470	281	187	162	121	60	986
Saveria Capria Italy	19	543 1.2×	442 1.6×	163 0.9×	278 1.7×	209 1.7×	70	1.3k
E Signer Switzerland	20	433 0.9×	160 0.6×	101 0.5×	120 0.7×	56 0.5×	50	1.1k
Bernard L. Marini United States	18	186 0.4×	230 0.8×	159 0.9×	163 1.0×	54 0.4×	89	914
Neşe Yaralı Türkiye	16	491 1.0×	135 0.5×	301 1.6×	137 0.8×	30 0.2×	137	1.1k
Aaron Cumpston United States	17	295 0.6×	199 0.7×	64 0.3×	243 1.5×	46 0.4×	55	722
Curt A. Ries United States	17	335 0.7×	355 1.3×	92 0.5×	293 1.8×	52 0.4×	27	1.1k
Jan Goßmann Germany	20	151 0.3×	387 1.4×	79 0.4×	194 1.2×	56 0.5×	42	1.4k
Brett Glotzbecker United States	18	753 1.6×	484 1.7×	99 0.5×	112 0.7×	111 0.9×	53	1.3k
Charles R.J. Singer United Kingdom	17	419 0.9×	269 1.0×	112 0.6×	47 0.3×	52 0.4×	40	964
V. P. Choudhry India	20	762 1.6×	69 0.2×	458 2.4×	103 0.6×	55 0.5×	117	1.3k

Countries citing papers authored by Richard J. Creger

Since Specialization

Citations

This map shows the geographic impact of Richard J. Creger's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Richard J. Creger with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Richard J. Creger more than expected).

Fields of papers citing papers by Richard J. Creger

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Richard J. Creger. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Richard J. Creger. The network helps show where Richard J. Creger may publish in the future.

Co-authorship network of co-authors of Richard J. Creger

This figure shows the co-authorship network connecting the top 25 collaborators of Richard J. Creger. A scholar is included among the top collaborators of Richard J. Creger based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Richard J. Creger. Richard J. Creger is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Ueda, Masumi, Tammy Stefan, Lindsay Stetson, et al.. (2020). Phase I Trial of Lithium and Tretinoin for Treatment of Relapsed and Refractory Non-promyelocytic Acute Myeloid Leukemia. Frontiers in Oncology. 10. 327–327. 9 indexed citations

Malek, Ehsan, Vinita Gupta, Richard J. Creger, et al.. (2018). Amifostine reduces gastro-intestinal toxicity after autologous transplantation for multiple myeloma. Leukemia & lymphoma. 59(8). 1905–1912. 8 indexed citations

Cooper, Brenda, Paolo F. Caimi, Ehsan Malek, et al.. (2018). Vascular Access and Bloodstream Infections Associated with Tunneled, Non-Trialysis and Non-Tunneled, Trialysis Catheters in Patients Undergoing Hematopoietic Stem Cell Transplantation. Biology of Blood and Marrow Transplantation. 24(3). S311–S312.

Sundaram, Suchitra, Benjamin Tomlinson, Richard J. Creger, et al.. (2017). Early Cardiovascular Toxicity with Treatment of Follicular Lymphoma Is Associated with Shorter Overall Survival. Blood. 130. 2776–2776. 2 indexed citations

Malek, Ehsan, Richard J. Creger, Fahrettin Covut, et al.. (2017). Reducing Gastrointestinal Toxicity Associated with Autologous Transplantation for Multiple Myeloma without Compromising Its Anti-Myeloma Effect. Blood. 130(Suppl_1). 680–680. 3 indexed citations

Cooper, Brenda, Tamila L. Kindwall‐Keller, Michael Craig, et al.. (2015). A Phase I Study of Midostaurin and Azacitidine in Relapsed and Elderly AML Patients. Clinical Lymphoma Myeloma & Leukemia. 15(7). 428–432.e2. 63 indexed citations

Caimi, Paolo F., Basem M. William, Pingfu Fu, et al.. (2015). Comparison of 2 Carmustine-Containing Regimens in the Rituximab Era: Excellent Outcomes Even in Poor-Risk Patients. Biology of Blood and Marrow Transplantation. 21(11). 1926–1931. 3 indexed citations

Kindwall‐Keller, Tamila L., Hillard M. Lazarus, Mary J. Laughlin, et al.. (2013). Charlson Comorbidity Index (CCI) and Hematopoietic Cell Transplantation Specific-Comorbidity Index (HCT-CI) Do Not Predict Transplant Related Mortality (TRM) and Post-Transplant Outcomes In Young Patients Undergoing Reduced Intensity Conditioning (RIC) Umbilical Cord Blood (UCB) Transplantation. Blood. 122(21). 4582–4582.

Kindwall‐Keller, Tamila L., Howard Meyerson, Seunghee Margevicius, et al.. (2011). Prospective study of one- vs two-unit umbilical cord blood transplantation following reduced intensity conditioning in adults with hematological malignancies. Bone Marrow Transplantation. 47(7). 924–933. 42 indexed citations

10.

Heeckeren, Willem J. van, Laura R. Fanning, Howard Meyerson, et al.. (2007). Influence of human leucocyte antigen disparity and graft lymphocytes on allogeneic engraftment and survival after umbilical cord blood transplant in adults. British Journal of Haematology. 139(3). 464–474. 21 indexed citations

11.

Reed, Michael D., et al.. (2005). Transfer of the hematopoietic stem cell transplant patient to the intensive care unit: does it really matter?. Bone Marrow Transplantation. 37(2). 119–133. 48 indexed citations

12.

Lazarus, Hillard M., Richard J. Creger, Rasim Gucalp, et al.. (1996). Cefoperazone/sulbactam versus cefoperazone plus mezlocillin: empiric therapy for febrile, neutropenic bone marrow transplant patients. International Journal of Antimicrobial Agents. 7(2). 85–91. 3 indexed citations

13.

Remler, Bernd F., Richard J. Creger, Brenda Cooper, et al.. (1996). Delayed, transient encephalopathy after marrow transplantation: case reports and MRI findings in four patients. Journal of Neuro-Oncology. 27(3). 241–250. 3 indexed citations

14.

Fox, R M, et al.. (1996). Microbiologic contamination of peripheral blood progenitor cells collected for hematopoietic cell transplantation. Transfusion. 36(9). 789–793. 35 indexed citations

15.

Weber, F, Richard J. Creger, R M Fox, et al.. (1995). Acute cholecystitis after autologous bone marrow transplantation for acute myeloid leukemia. Annals of Oncology. 6(3). 302–304. 5 indexed citations

16.

Cooper, Brenda, et al.. (1993). Renal dysfunction during high-dose cisplatin therapy and autologous hematopoietic stem cell transplantation: Effect of aminoglycoside therapy. The American Journal of Medicine. 94(5). 497–504. 6 indexed citations

17.

Spitzer, Thomas R., Hillard M. Lazarus, Richard J. Creger, & Nathan A. Berger. (1989). High-Dose Melphalan, Misonidazole, and Autologous Bone Marrow Transplantation for the Treatment of Metastatic Colorectal Carcinoma. American Journal of Clinical Oncology. 12(2). 145–151. 6 indexed citations

18.

Danziger, Larry H., et al.. (1988). Randomized Trial of Imipenem‐Cilastatin versus Gentamicin Plus Clindamycin in the Treatment of Polymicrobial Infections. Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy. 8(6). 315–318. 7 indexed citations

19.

King, Charles H., Richard J. Creger, & Jerrold J. Ellner. (1985). Pharmacokinetics of tobramycin and gentamicin in abusers of intravenous drugs. Antimicrobial Agents and Chemotherapy. 27(3). 285–290. 23 indexed citations

20.

Creger, Richard J., et al.. (1983). Dose-Dependent Theophylline Elimination in an Adult. Drug Intelligence & Clinical Pharmacy. 17(3). 202–204. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact